0001556663-20-000001.txt : 20201113 0001556663-20-000001.hdr.sgml : 20201113 20201112181457 ACCESSION NUMBER: 0001556663-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201113 DATE AS OF CHANGE: 20201112 EFFECTIVENESS DATE: 20201113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cure Pharmaceutical Holding Corp. CENTRAL INDEX KEY: 0001643301 STANDARD INDUSTRIAL CLASSIFICATION: PLASTICS, FOIL & COATED PAPER BAGS [2673] IRS NUMBER: 371765151 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-380452 FILM NUMBER: 201308413 BUSINESS ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 BUSINESS PHONE: 805-824-0410 MAIL ADDRESS: STREET 1: 1620 BEACON PLACE CITY: OXNARD STATE: CA ZIP: 93033 FORMER COMPANY: FORMER CONFORMED NAME: Makkanotti Group Corp. DATE OF NAME CHANGE: 20150526 D 1 primary_doc.xml X0708 D LIVE 0001643301 Cure Pharmaceutical Holding Corp. 1620 BEACON PLACE OXNARD CA CALIFORNIA 93033 805-824-0410 DELAWARE Makkanotti Group Corp. Corporation true Robert Davidson 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Executive Officer Director John Bell 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Lauren Chung 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Anya Goldin 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Josh Held 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Ruben King-Shaw 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Gene Salkind 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director William Yuan 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Nancy Duitch 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Director Mike Redard 1620 Beacon Place Oxnard CA CALIFORNIA 93033 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2020-10-30 false true true true false 0 Axiom Capital Management, Inc. 265801 None None 350 Fifth Avenue, Suite 5420 New York NY NEW YORK 10118 CA CALIFORNIA false 11500000 11500000 0 For further explanation, please see the Current Report on Form 8-K filed by the Issuer on November 2, 2020. false 1 0 306000 true Placement agent fee. This amount may increase up to an additional $480,000 upon achievement of certain milestones. 0 false Cure Pharmaceutical Holding Corp. /s/Mike Redard Mike Redard Chief Financial Officer 2020-11-12